Potent Dual Inhibitors of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for In Vivo Proof-of-Principle Studies in an Endometriosis Mouse Model.

MLA

Salah, Mohamed, et al. “Potent Dual Inhibitors of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for In Vivo Proof-of-Principle Studies in an Endometriosis Mouse Model.” Journal of Medicinal Chemistry, vol. 66, no. 13, July 2023, pp. 8975–92. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.3c00571.

APA

Salah, M., Tahoun, M., Rudzitis-Auth, J., Stotz, L., van Koppen, C. J., Laschke, M. W., Abdelsamie, A. S., & Frotscher, M. (2023). Potent Dual Inhibitors of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for In Vivo Proof-of-Principle Studies in an Endometriosis Mouse Model. Journal of Medicinal Chemistry, 66(13), 8975–8992. https://doi.org/10.1021/acs.jmedchem.3c00571

Chicago

Salah, Mohamed, Mariam Tahoun, Jeannette Rudzitis-Auth, Lisa Stotz, Chris J van Koppen, Matthias W Laschke, Ahmed S Abdelsamie, and Martin Frotscher. 2023. “Potent Dual Inhibitors of Steroid Sulfatase and 17β-Hydroxysteroid Dehydrogenase Type 1 with a Suitable Pharmacokinetic Profile for In Vivo Proof-of-Principle Studies in an Endometriosis Mouse Model.” Journal of Medicinal Chemistry 66 (13): 8975–92. doi:10.1021/acs.jmedchem.3c00571.